PGNY Insider Trading

Insider Ownership Percentage: 12.30%
Insider Buying (Last 12 Months): $5,235,560.00
Insider Selling (Last 12 Months): $4,166,391.62

Progyny Insider Trading History Chart

This chart shows the insider buying and selling history at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M-$50M$0$50M$100MTotal Insider BuyingTotal Insider Selling

Progyny Share Price & Price History

Current Price: $19.95
Price Change: Price Increase of +0.13 (0.66%)
As of 03/11/2025 05:00 PM ET

This chart shows the closing price history over time for PGNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$19.95Closing price on 03/11/25:

SEC Filings (Institutional Ownership Changes) for Progyny (NASDAQ:PGNY)

94.93% of Progyny stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PGNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$222Mbought$143MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More on Progyny

Today's Range

Now: $19.95
Low: $19.54
High: $20.12

50 Day Range

MA: $21.43
Low: $17.25
High: $23.88

52 Week Range

Now: $19.95
Low: $13.39
High: $38.98

Volume

1,652,142 shs

Average Volume

1,576,217 shs

Market Capitalization

$1.70 billion

P/E Ratio

34.40

Dividend Yield

N/A

Beta

1.41

Who are the company insiders with the largest holdings of Progyny?

Progyny's top insider investors include:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Peter Anevski (CEO)
  3. Michael E Sturmer (President)
  4. David J Schlanger (Chairman)
  5. Mark S Livingston (CFO)
  6. Kevin K Gordon (Director)
  7. Cheryl Scott (Director)
Learn More about top insider investors at Progyny.

Who are the major institutional investors of Progyny?

Progyny's top institutional investors include:
  1. Vanguard Group Inc. — 10.21%
  2. Pacer Advisors Inc. — 4.32%
  3. T. Rowe Price Investment Management Inc. — 3.83%
  4. Geode Capital Management LLC — 2.14%
  5. Fred Alger Management LLC — 1.93%
  6. Invenomic Capital Management LP — 1.91%
Learn More about top institutional investors of Progyny stock.

Which major investors are selling Progyny stock?

In the previous quarter, PGNY stock was sold by these institutional investors:
  1. International Assets Investment Management LLC
  2. Farallon Capital Management LLC
  3. Kornitzer Capital Management Inc. KS
  4. Principal Financial Group Inc.
  5. Fred Alger Management LLC
  6. Point72 Asset Management L.P.
  7. New York State Common Retirement Fund
  8. T. Rowe Price Investment Management Inc.
Within the previous year, company insiders that have sold Progyny company stock include:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Peter Anevski (CEO)
  3. Michael E Sturmer (President)
  4. David J Schlanger (Chairman)
Learn More investors selling Progyny stock.

Which major investors are buying Progyny stock?

Within the last quarter, PGNY stock was purchased by institutional investors including:
  1. River Road Asset Management LLC
  2. Pacer Advisors Inc.
  3. Fort Washington Investment Advisors Inc. OH
  4. Barclays PLC
  5. D. E. Shaw & Co. Inc.
  6. BNP Paribas Financial Markets
  7. First Sabrepoint Capital Management LP
  8. Voloridge Investment Management LLC
In the last year, these company insiders have bought Progyny stock:
  1. Tpg Gp A, Llc (Major Shareholder)
  2. Peter Anevski (CEO)
Learn More investors buying Progyny stock.